XML 117 R90.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock-Based Compensation Programs (Details)
1 Months Ended 12 Months Ended
Jul. 31, 2016
$ / shares
Jan. 31, 2016
$ / shares
shares
Feb. 28, 2015
$ / shares
Jan. 31, 2014
$ / shares
Dec. 31, 2016
USD ($)
installment
$ / shares
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Dec. 31, 2014
USD ($)
shares
Restricted stock activity, Weighted average grant price              
Unrecognized compensation cost related to nonvested share-based compensation arrangements | $         $ 57,000,000    
Expected weighted-average period for recognition of unrecognized stock-based compensation costs         2 years 6 months    
Selling, general and administrative              
Restricted stock activity, Weighted average grant price              
Share based compensation expense | $         $ 35,000,000 $ 25,000,000 $ 25,000,000
Expenses for share-based compensation arrangements, after tax | $         $ 22,000,000 $ 15,000,000 $ 16,000,000
Stock option and SSARs              
Stock-Based Compensation Programs              
Number of equal installments commencing one year from the date of grant | installment         4    
Vesting period         1 year    
Expiration period of options         10 years    
Outstanding Options, Number of Shares              
Beginning of year (in shares)           9,716,251  
Granted (in shares)         1,287,432    
Exercised (in shares)         (2,040,183)    
Canceled/forfeited (in shares)         (290,309)    
End of the period (in shares)         8,673,191   9,716,251
Vested and exercisable, end of period (in shares)         5,937,866    
Reserved for future grants (in shares)         4,809,631    
Outstanding Options, Weighted Average Exercise Price              
Beginning of year (in dollars per share) | $ / shares   $ 37.50     $ 37.50    
Granted (in dollars per share) | $ / shares         67.21    
Exercised (in dollars per share) | $ / shares         31.81    
Canceled/forfeited (in dollars per share) | $ / shares         57.72    
End of period (in dollars per share) | $ / shares         42.57 $ 37.50  
Vested and exercisable, end of period (in dollars per share) | $ / shares         $ 33.71    
Additional disclosures              
Weighted average remaining contractual term of options outstanding           5 years 2 months 12 days  
Aggregate intrinsic value of options outstanding | $         $ 282,000,000    
Weighted average remaining contractual term of options vested and exercisable           3 years 10 months 24 days  
Aggregate intrinsic value of options vested and exercisable | $         246,000,000    
Total fair value of options vested | $         $ 13,000,000 $ 12,000,000 $ 13,000,000
Weighted average fair value at grant date (in dollars per share) | $ / shares $ 16.71 $ 18.58 $ 14.20 $ 9.81      
Weighted average assumptions used in estimation of fair values of options              
Expected dividend yield (as a percent)         0.73% 0.79% 1.06%
Expected stock price volatility (as a percent)         24.14% 22.11% 21.41%
Risk-free interest rate (as a percent)         1.22% 1.39% 1.65%
Expected life of options         6 years 1 month 6 days 5 years 10 months 6 days 5 years 6 months
Stock options              
Additional disclosures              
Cash received from options exercised | $         $ 36,000,000 $ 22,000,000 $ 23,000,000
Intrinsic value of options exercised | $         45,000,000 33,000,000 31,000,000
Tax benefit from exercise of options | $         $ 22,000,000    
Restricted stock activity, Weighted average grant price              
Maximum employer's contribution as a percentage of each participating employee's monthly payroll deduction         20.00%    
Maximum employer's contribution to each participating employee | $         $ 500    
Company contributions | $         $ 4,000,000 $ 4,000,000 $ 4,000,000
Restricted shares and restricted stock units              
Stock-Based Compensation Programs              
Vesting period         5 years    
Restricted stock activity, Number of shares              
Beginning of the period (in shares)   861,945     861,945    
Granted (in shares)         382,903    
Vested (in shares)         (201,662)    
Canceled/forfeited (in shares)         (25,125)    
End of the period (in shares)         1,018,061 861,945  
Restricted stock activity, Weighted average grant price              
Beginning of the period (in dollars per share) | $ / shares   $ 45.27     $ 45.27    
Granted (in dollars per share) | $ / shares         74.13    
Vested (in dollars per share) | $ / shares         46.90    
Canceled/forfeited (in dollars per share) | $ / shares         52.79    
End of the period (in dollars per share) | $ / shares         $ 55.62 $ 45.27  
PCEQs              
Stock-Based Compensation Programs              
Vesting period         3 years    
Restricted stock activity, Number of shares              
Granted (in shares)         132,818 116,559 143,305
Restricted stock activity, Weighted average grant price              
Share based compensation expense | $         $ 15,000,000 $ 2,016,000,000 $ 7,000,000
PCEQs | Minimum              
Restricted stock activity, Weighted average grant price              
Vest range of participant's assigned award opportunity (as a percent)         0.00%    
PCEQs | Maximum              
Restricted stock activity, Weighted average grant price              
Vest range of participant's assigned award opportunity (as a percent)         200.00%